###begin article-title 0
###xml 68 73 <span type="species:ncbi:9606">Human</span>
A Decline in CCL3-5 Chemokine Gene Expression during Primary Simian-Human Immunodeficiency Virus Infection
###end article-title 0
###begin p 1
Conceived and designed the experiments: KS WZ. Performed the experiments: WZ BP JB XA. Analyzed the data: KS WZ. Contributed reagents/materials/analysis tools: BP. Wrote the paper: KS WZ.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 146 154 146 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 164 171 164 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 88 91 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 208 213 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The CC-chemokines CCL3, CCL4 and CCL5 have been found to block the entry of CCR5-tropic HIV into host cells and to suppress the viral replication in vitro, but the in vivo role of endogenous CC-chemokines in HIV-1 infection is still incompletely understood.
###end p 3
###begin title 4
Methodology/Principle Findings
###end title 4
###begin p 5
###xml 233 240 233 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 456 459 456 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 648 655 648 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 885 888 885 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 903 910 903 910 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 104 132 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 134 138 <span type="species:ncbi:12721">SHIV</span>
###xml 153 167 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 180 195 <span type="species:ncbi:9544">rhesus macaques</span>
In this study, the primate host CCL3, CCL4 and CCL5 gene expression was evaluated in response to simian-human immunodeficiency virus (SHIV) infection in rhesus macaque model. Five rhesus macaques were inoculated with CCR5-tropic SHIVSF162P4. The mRNA levels of CCL3, CCL4 and CCL5 were measured by real-time PCR at post inoculation day (PID) 0, 7, 14, 21, 35, 56 and 180 in peripheral blood. In addition, a selected subset of samples from CXCR4-tropic SHIVKu1-infected macaques was included with objective to compare the differences in CC-chemokine down-regulation caused by the two SHIVs. Gut-associated lymphoid tissues (GALT) collected from SHIVSF162P4-infected animals were also tested by flow cytometry and confocal microscopy to corroborate the gene expression results. Predictably, higher viral loads and CD4+ T cell losses were observed at PID 14 in macaques infected with SHIVKu1 than with SHIVSF162P4. A decline in CC-chemokine gene expression was also found during primary (PID 7-21), but not chronic (PID 180) stage of infection.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 30 37 30 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 156 159 156 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 361 364 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
It was determined that A) SHIVSF162P4 down-regulated the CC-chemokine gene expression during acute stage of infection to a greater extent (p<0.05) than SHIVKu1, and B) such down-regulation was not paralleled with the CD4+ T cell depletion. Evaluation of CC-chemokine enhancing immunomodulators such as synthetic CpG-oligonucleotides could be explored in future HIV vaccine studies.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 184 187 184 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Stein1">[1]</xref>
###xml 253 254 253 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 326 329 326 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Zlotnik1">[2]</xref>
###xml 393 396 393 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Zlotnik1">[2]</xref>
###xml 669 672 669 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Berger1">[3]</xref>
###xml 674 677 674 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Moser1">[4]</xref>
###xml 929 932 929 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Berger1">[3]</xref>
###xml 1133 1136 1133 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Liu1">[5]</xref>
###xml 1289 1292 1289 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Rottman1">[6]</xref>
###xml 1293 1296 1293 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Zhang1">[8]</xref>
###xml 514 519 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 663 668 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 679 684 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 817 822 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 961 966 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1071 1076 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Chemokines play a critical role in the host defense against viruses by mobilizing leukocytes to sites of infection, and they also play a homeostatic role in secondary lymphoid tissues [1]. Structurally, chemokines are divided into the C, CC, CXC, and CX3C subclasses on the basis of their N-terminal cysteine residues spacing [2]. The majority of known chemokines belong to CC or CXC category [2]. Since CC chemokine receptor 5 (CCR5) and CXC chemokine receptor 4 (CXCR4) were identified as major co-receptors for HIV-1 entry into target cells, it was suggested that these chemokine receptors and their ligands are involved in the transmission and replication of HIV-1 [3], [4]. HIV-1 isolates that use CCR5 as co-receptor (R5 viruses) are predominantly transmitted and persist throughout the infection. By contrast, HIV-1 isolates that use CXCR4 (X4 viruses) commonly emerge in infected individuals at later stages of infection [3]. The importance of CCR5 for HIV-1 transmission was underscored by observation that certain individuals who had been repeatedly exposed to HIV-1 but remained uninfected had a defect in CCR5 expression [5]. It has been documented that mucosa-associated CD4+ T cells, macrophages, and dendritic cells express CCR5 which makes them prime targets for the virus [6]-[8].
###end p 9
###begin p 10
###xml 226 234 219 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 283 286 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Cocchi1">[9]</xref>
###xml 287 291 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Mackewicz1">[11]</xref>
###xml 340 344 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Alkhatib1">[12]</xref>
###xml 359 366 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 604 608 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Ahmed1">[13]</xref>
###xml 609 613 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Paxton2">[18]</xref>
###xml 714 718 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Ahmed1">[13]</xref>
###xml 720 724 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Lehner1">[16]</xref>
###xml 725 729 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Paxton2">[18]</xref>
###xml 837 841 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Jennes1">[14]</xref>
###xml 843 847 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-LaFrancoScheuch1">[15]</xref>
###xml 198 203 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 423 428 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 537 542 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 543 546 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 694 699 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 700 703 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 813 816 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 927 932 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 933 936 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1012 1017 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Members of the CC-chemokine family, such as macrophage inflammatory protein (MIP)-1alpha (CCL3), MIP-1beta (CCL4) and RANTES (CCL5) are the natural ligands for CCR5. They have been shown to inhibit HIV-1 entry into host cells in vitro by competing with viral Env protein for binding [9]-[11], and by down-regulating CCR5 surface expression [12]. However, the in vivo role of endogenous CC-chemokines in the pathogenesis of HIV-1 infection is still incompletely understood. A number of studies have analyzed levels of CCR5 ligands in the HIV-1/SIV-infected individuals or monkeys with conflicting results [13]-[18]. Some of these studies concluded that CCR5 ligands may exert protective role in HIV-1/SIV infection [13], [16]-[18], while others suggested an association between elevated levels of CCR5 ligands and HIV disease progression [14], [15]. Most of these reports were based on data that correspond to chronic stages of HIV-1/SIV infection, while the relationship between host CC-chemokine expression and HIV-1 acute infection still needs to be studied.
###end p 10
###begin p 11
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 140 147 140 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 368 371 368 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 503 511 503 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4 </sub>
###xml 548 551 548 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 108 112 <span type="species:ncbi:12721">SHIV</span>
###xml 148 162 <span type="species:ncbi:9544">rhesus macaque</span>
In this study, we evaluated the host in vivo CCL3, CCL4 and CCL5 gene expression in response to CCR5-tropic SHIV infection. We utilized SHIVSF162P4/rhesus macaque model and focused predominantly on acute stage of infection to measure the CC-chemokine gene expression changes in peripheral blood and GALT. In addition, we included a selected subset of samples from SHIVKu1-infected macaques in order to compare the differences between the extent of CC-chemokine down-regulation caused by CCR5-tropic SHIVSF162P4 and more pathogenic CXCR4-tropic SHIVKu1 at the acute stage of infection.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 62 69 62 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
Viral loads and CD4+ T cell counts in peripheral blood of SHIVSF162P4-infected macaques
###end title 13
###begin p 14
###xml 13 20 13 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 188 189 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 207 214 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g001">Fig. 1A</xref>
###xml 303 310 291 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g001">Fig. 1B</xref>
All five SHIVSF162P4-inoculated macaques became infected as determined by individual viral load measurements. Highest viral loads were detected at PID 14 with an average of approximately105 of viral copies (Fig. 1A). The lowest average peripheral CD4+ T cell counts were detected between PID 14 and 21 (Fig. 1B).
###end p 14
###begin title 15
###xml 4 11 4 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 172 179 172 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
SHIVSF162P4 loads in plasma (A), CD4+ T cell counts in peripheral blood (B), relative CCL3 (C), CCL4 (D) and CCL5 (E) gene expression levels in PBMCs at PID 0-180 with SHIVSF162P4.
###end title 15
###begin p 16
Each point on the graph represents the mean fold change in gene expression relative to pre-infection level+/-SE (n = 5).
###end p 16
###begin title 17
###xml 75 82 75 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
Down-regulation of CC-chemokine gene expression in peripheral blood of SHIVSF162P4-infected macaques
###end title 17
###begin p 18
###xml 138 145 138 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 324 331 324 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 343 362 343 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g001">Fig. 1A, C, D and E</xref>
###xml 585 601 585 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g001">Fig. 1C, D and E</xref>
The changes of CCL3, CCL4 and CCL5 gene expression levels were studied in peripheral blood over the period of half year following the SHIVSF162P4 inoculation. Decreased expression of all three CC-chemokines was found upon infection. The lowest gene expression was detected at PID 14, coinciding with the peak of primary SHIVSF162P4 infection (Fig. 1A, C, D and E). By PID 14, CCL3, CCL4 and CCL5 mRNA levels decreased 5.9-13.6, 3.5-27.5, and 2.3-5.4-folds, respectively. These levels were significantly lower (p<0.005 for CCL3; p<0.05 for CCL4 and CCL5) than those prior to infection (Fig. 1C, D and E). However, such a decline of CC-chemokine gene expression occurred only temporarily, because starting from PID 21 and at later time points these gene expression values showed relative increase. By PID 180, expressions of all three chemokine genes were no longer significantly different from those prior to infection.
###end p 18
###begin title 19
###xml 63 70 63 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
Down-regulation of CC-chemokine gene expression in GALT of SHIVSF162P4-infected macaques
###end title 19
###begin p 20
###xml 94 101 94 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 304 317 302 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g002">Fig. 2A and B</xref>
To determine whether the decline of CC-chemokine gene expression occurred also in GALT of SHIVSF162P4-infected macaques, biopsy samples of colon, jejunum and MLN were obtained at PID 0, 14 and 180. At PID 14, CCL3 and CCL4 mRNA levels in colon, jejunum and MLN were lower (p</=0.05) than those at PID 0 (Fig. 2A and B). CCL5 mRNA decreased in jejunum (p<0.05) but not in colon and MLN. In agreement with results generated with PBMC, down-regulation of CC-chemokines occurred also in GALT at PID 14. By PID 180, expression of CC-chemokines returned to pre-infection levels (CCL4 and CCL5), or even increased (CCL3).
###end p 20
###begin title 21
###xml 102 109 102 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
Relative CCL3 (A), CCL4 (B) and CCL5 (C) expression levels in GALT tissues at different stages of SHIVSF162P4 infection (n = 5).
###end title 21
###begin p 22
PID 0 was used as the calibrator (value = 1).
###end p 22
###begin title 23
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 42 49 42 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
In situ enumeration of CCL4+ cells in SHIVSF162P4-infected macaques
###end title 23
###begin p 24
###xml 111 118 111 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 331 338 331 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 362 369 362 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g003">Figs. 3</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g004">4</xref>
###xml 445 452 445 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000726-t001">Table 1</xref>
###xml 591 597 591 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g003">Fig. 3</xref>
###xml 682 688 682 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g004">Fig. 4</xref>
###xml 829 836 829 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000726-t001">Table 1</xref>
To corroborate the mRNA results, and to determine the origin and number of CC-chemokine-producing cells in SHIVSF162P4-infected macaques, confocal microscopy and MLN tissues were used. The CCL4 was selected as the CC-chemokine representative. The T lymphocytes (CD3+), macrophages (CD68+), and CCL4+ cells were identified directly in situ by tri-color staining (Figs. 3 and 4). Higher number of CD3+CCL4+ cells was seen at PID 0 than at PID 14 (Table 1) while CD3+p28+ cells were seen at PID 14 but not at PID 0 indicating the rapid spread of virus into GALTs following mucosal inoculation (Fig. 3). In addition to CD3+ cells, CD68+ macrophages were also identified as CCL4+ cells (Fig. 4). In agreement with real-time PCR data, the counts of CD3+CCL4+ and CD68+CCL4+ cells were lower (p<0.05) at PID 14 than they were at PID 0 (Table 1).
###end p 24
###begin title 25
###xml 112 119 112 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
Triple-label confocal microscopy of CCL4+ cells in mesenteric lymph nodes obtained from control (PID 0) and SHIVSF162P4-inoculated macaques at PID 14.
###end title 25
###begin p 26
###xml 57 64 57 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 254 261 254 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000726-t001">Table 1</xref>
T lymphocytes (CD3+) are red, CCL4+ cells are green, SHIVSF162P4-infected cells (p28+) are blue. Overlap of red and green fluorescence is seen as yellow, overlap of red and blue as pink. Higher number of CD3+CCL4+ cells was seen at PID 0 than at PID 14 (Table 1) while CD3+p28+ cells could be seen at PID 14 but not at PID 0 indicating the successful spread of virus into GALTs following mucosal inoculation.
###end p 26
###begin title 27
Macrophages were also identified as CCL4+ cells.
###end title 27
###begin p 28
Macrophages (CD68+) are red, CCL4+ cells are green, overlap of red and green fluorescence is seen as yellow.
###end p 28
###begin title 29
###xml 78 85 78 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
Absolute (counts) and relative (%) levels of CCL4+ cells in MLN following SHIVSF162P4 inoculation
###end title 29
###begin p 30
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Number of cells/0.5 mm2 section.
###end p 30
###begin title 31
###xml 57 64 57 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
Flow cytometry of CCL4+ cells in peripheral blood of SHIVSF162P4-infected macaques
###end title 31
###begin p 32
###xml 206 213 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g005">Fig. 5B</xref>
###xml 301 308 301 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g005">Fig. 5B</xref>
###xml 431 438 431 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g005">Fig. 5A</xref>
Four-color flow cytometry was used to corroborate the gene expression results. At PID 0, the average proportions of CD3+CD4+CCL4+ and CD3+CD8+CCL4+ cells over CD3+ T cells were 5.9% and 6.9%, respectively (Fig. 5B). By PID 14, both of these proportions decreased (p<0.05 and p<0.01) to 2.2% and 2.3% (Fig. 5B). In order to be able to differentiate between CCL4+ and CCL4- cells, mitogen-stimulated cells were included as controls (Fig. 5A).
###end p 32
###begin title 33
###xml 125 132 125 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
The proportions of peripheral blood CD3+CD4+CCL4+ and CD3+CD8+CCL4+ T lymphocytes were compared at PID 0 and PID 14 with SHIVSF162P4 by flow cytometry (A).
###end title 33
###begin p 34
Gating was performed via CD3+ lymphocyte population. Statistically significant differences between CD3+CD4+CCL4+ and CD3+CD8+CCL4+ cells over CD3+ lymphocytes at PID 0 vs. PID 14 (n = 5) are shown (B).
###end p 34
###begin title 35
###xml 60 64 <span type="species:ncbi:12721">SHIV</span>
The extent of CC-chemokine gene down-regulation in blood of SHIV-infected macaques is independent from the level of CD4+ T cell depletion
###end title 35
###begin p 36
###xml 25 32 25 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 287 290 287 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Belyakov1">[19]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Hsu1">[20]</xref>
###xml 395 398 395 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 540 547 540 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 549 562 549 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g006">Fig. 6A and B</xref>
###xml 584 591 584 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 783 786 783 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 806 813 806 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g006">Fig. 6C</xref>
###xml 878 885 878 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 895 898 895 898 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
We hypothesized that SHIVSF162P4-induced CC-chemokine down-regulation at acute stage of infection was not proportionately related to peripheral CD4+ T cell depletion as a result of viral target cell destruction. Therefore, we included in this study a subset of samples obtained from SHIVKu1-infected macaques (PID 0 and 14). In accord with previous reports [19], [20], it was confirmed that SHIVKu1 infection was at PID 14 associated with greater plasma viral loads and more profound loss of peripheral CD4+ T cells than that caused by SHIVSF162P4 (Fig. 6A and B). Interestingly, SHIVSF162P4 caused by PID 14 5.9-13.6, 3.5-27.5, and 2.3-5.4-fold CCL3, CCL4 and CCL5 gene down-regulation respectively, while only 2.8-6.2, 2.3-7.8, and 1.2-2.2-fold down-regulation was measured in SHIVKu1-infected macaques (Fig. 6C). These differences in CC-chemokine down-regulation between SHIVSF162P4- and SHIVKu1-infected macaques were significant (p<0.05).
###end p 36
###begin title 37
###xml 18 26 18 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4 </sub>
###xml 34 37 34 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
Comparison of SHIVSF162P4 and SHIVKu1 primary infection in peripheral blood.
###end title 37
###begin p 38
###xml 117 124 117 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 134 137 134 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
Viral loads in plasma (A), CD4+ T cell counts (B), Fold-changes of CCL3, CCL4 and CCL5 gene expression levels in SHIVSF162P4- and SHIVKu1-infected macaques at PID 0 vs. PID 14 (C) (n = 5 for each group). Negative sample cut-off for viral load measurements in plasma was <30 copies/ml e.g. PID 0 value.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 92 99 92 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Mattapallil1">[21]</xref>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Wen1">[22]</xref>
###xml 905 909 905 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Jennes1">[14]</xref>
###xml 911 915 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-LaFrancoScheuch1">[15]</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-HofmannLehmann1">[23]</xref>
###xml 1114 1121 1114 1121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF164P4</sub>
###xml 1171 1178 1171 1178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF164P4</sub>
###xml 627 630 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 777 782 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 887 890 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 891 894 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Main objective of our study was to evaluate the CC-chemokine gene expression changes in SHIVSF162P4-infected macaques. We found that at primary/acute stage of infection, CC-chemokine genes were markedly down-regulated, which coincided with the peak of viremia. Gene expression results were consistent with direct measurements of chemokine production-corroborated by confocal microscopy and flow cytometry. Results generated with peripheral blood and GALT samples were also consistent. In agreement with our results, a decline in CCL4 gene expression by CD8+ intraepithelial lymphocytes (IEL) was observed at the acute stage of SIV infection [21]. Study by Wen and colleagues [22] also showed that expression of CCL3, CCL4 and CCL5 decreased in U937 promonocytes in response to HIV-1 infection. In addition, several studies reported up-regulation of CC-chemokines during chronic phase of HIV/SIV infection [14], [15], [23]. These reports are not in conflict with our results. Results shown here indicate however that down-regulation of CCR5 ligands occurred only at primary (PID 14) but not at chronic stage of SHIVSF164P4 infection (PID 180). At the chronic stage of SHIVSF164P4 infection, expression of the CCR5 ligands returned to pre-infection levels (CCL4 and CCL5), or even increased (CCL3) in all three GALTs.
###end p 40
###begin p 41
###xml 307 314 307 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 481 484 481 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 575 582 575 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 839 846 839 846 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 918 921 918 921 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 1235 1239 1235 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Decrion1">[24]</xref>
###xml 1353 1357 1353 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Muthumani1">[25]</xref>
###xml 1599 1603 1599 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Kinter1">[26]</xref>
###xml 1605 1609 1605 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Stantchev1">[27]</xref>
###xml 90 94 <span type="species:ncbi:12721">SHIV</span>
###xml 431 434 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 438 441 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1106 1110 <span type="species:ncbi:12721">SHIV</span>
###xml 1154 1158 <span type="species:ncbi:12721">SHIV</span>
###xml 1254 1257 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1416 1419 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1420 1423 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
There are several possible mechanisms involved in decline of CC-chemokines during primary SHIV infection. Since lymphocytes are CC-chemokine producing cells, the depletion of CD4+ T lymphocytes could be one of the reasons. Based on measurable and significant CC-chemokine gene down-regulation caused by SHIVSF162P4 that is known to be less pathogenic in term of its ability to deplete the peripheral CD4+ T cells than other SHIVs, SIV or HIV, a subset of samples obtained from SHIVKu1-infected macaques (PID 0 and 14) was included in this study. It was hypothesized that SHIVSF162P4-induced CC-chemokine down-regulation is not directly related to peripheral CD4+ T cell depletion-as a result of viral target cell destruction. This hypothesis was conclusively corroborated by measurements of CC-chemokine gene expression at PID 14 when SHIVSF162P4 was found to cause significantly greater gene down-regulation than SHIVKu1. Such result suggests that decline of CC-chemokines cannot be solely attributed to CD4+ T cell depletion, but it is more complex and likely linked to other pathways triggered by acute SHIV infection. One of them might be related to SHIV gene products, which modulate transcriptional levels of host response genes [24]. For example, HIV accessory gene product Vpr has been reported to suppress the host CC-chemokine gene expression [25]. Another candidate pathway is the interaction between the HIV/SIV gp120 and the CCR5 chemokine co-receptors, which trigger not only viral entry but also other signal transduction cascades that are impacting host CC-chemokine gene expression [26], [27]. Elucidating such pathways in context of CC-chemokine production can be subject of future studies.
###end p 41
###begin p 42
###xml 88 91 88 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Berger1">[3]</xref>
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Cocchi1">[9]</xref>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Gauduin1">[10]</xref>
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Stein1">[1]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Dorner1">[28]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Luther1">[29]</xref>
###xml 756 760 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Ahmed1">[13]</xref>
###xml 762 766 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Lehner1">[16]</xref>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Ahmed2">[30]</xref>
###xml 846 852 846 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mac251</sub>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Veazey1">[31]</xref>
###xml 68 71 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 72 75 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 146 149 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 150 153 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 578 581 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 582 585 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 742 745 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 868 882 <span type="species:ncbi:9544">rhesus monkeys</span>
CCL3, CCL4 and CCL5 function as natural ligands for CCR5, the major HIV/SIV co-receptor [3]. CC-chemokines are known to inhibit the CCR5-mediated HIV/SIV infection by blocking the viral entry into host cells [9], [10]. In addition, CC-chemokines play a role in directing the cell movements necessary for the initiation of T cell immune responses [1], co-stimulate the T cell proliferation, and augment the cytolytic capacity of T and NK cells [28], [29]. Thus, suppression of CC-chemokines during primary/acute stage of infection may be an event that facilitates the evasion of HIV/SIV from the host immune response. It was demonstrated by several authors that production of CC-chemokines was associated with vaccine-mediated protection from SIV challenge [13], [16], [30]. Furthermore, systemic therapy with CC-chemokine homologues decreased SIVmac251 replication in rhesus monkeys [31]. These reports are in agreement with our findings by corroborating the notion that CC-chemokine down-regulation may facilitate virus spread during acute stage of infection.
###end p 42
###begin p 43
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Moser2">[32]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Fantuzzi1">[33]</xref>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Mattapallil1">[21]</xref>
###xml 547 554 547 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 87 91 <span type="species:ncbi:12721">SHIV</span>
It may be unexpected that CCL3, CCL4 and CCL5 are down-regulated at the acute phase of SHIV infection, since most of the CC-chemokines belong to proinflammatory chemokines and are generally considered to be produced only in response to pathological conditions [32]. However, the constitutive expression of CCL3, CCL4 and CCL5 was detected in monocytes [33] and CD8+ intraepithelial lymphocytes [21]. In this study, highly sensitive real-time PCR was used to measure the expression of the above CC-chemokines in PBMC and GALTs before and after SHIVSF162P4 infection, and it was concluded that these chemokines are down-regulated during primary infection.
###end p 43
###begin p 44
###xml 113 116 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 117 120 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 261 268 <span type="species:ncbi:57667">SIV/HIV</span>
In summary, we hypothesize that an interventional up-regulation of CC-chemokines might lead to better outcome of HIV/SIV primary infection. Evaluation of CC-chemokine enhancing immunomodulators such as synthetic CpG-oligonucleotides could be explored in future SIV/HIV vaccine studies.
###end p 44
###begin title 45
Materials and methods
###end title 45
###begin title 46
Animals and virus
###end title 46
###begin p 47
###xml 28 42 28 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca mulatta</italic>
###xml 92 94 92 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 114 121 114 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Belyakov1">[19]</xref>
###xml 154 161 154 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 570 573 570 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 634 641 634 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 647 650 647 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 715 723 715 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Harouse1">[34]</xref>
###xml 753 757 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Joag1">[35]</xref>
###xml 11 26 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 28 42 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 499 514 <span type="species:ncbi:9544">rhesus macaques</span>
Five adult rhesus macaques (Macaca mulatta) of Indian origin were inoculated with 5,000 TCID50 of CCR5-tropic SHIVSF162P4 via intrarectal route [19]. SHIVSF162P4 was obtained from the Simian Retrovirus Core Laboratory at the TNPRC (Tulane National Primate Research Center). Animals were housed at the TNPRC under biosafety level 2 conditions in accordance with the regulations of the American Association for Assessment and Accreditation of Laboratory Animal Care standards. In addition, five adult rhesus macaques of Indian origin were inoculated with CXCR4-tropic SHIVKu1 by using the same route and dose as described above for SHIVSF162P4. SHIVKu1 was obtained from NIH (). Both SHIVs were expanded and titrated in vitro as described elsewhere [34], [35].
###end p 47
###begin title 48
Sample collection and storage
###end title 48
###begin p 49
###xml 39 46 39 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 475 476 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 769 772 747 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 965 972 943 950 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 982 985 960 963 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
From the 5 animals inoculated with SHIVSF162P4, EDTA blood was collected prior to inoculation (PID 0), and at PID 7, 14, 21, 35, 56 and 180. GALT samples (jejunum, colon and MLN) were collected via laparotomy biopsies at PID 0, 14 and 180. The peripheral blood mononuclear cells (PBMC) were isolated from EDTA blood using the lymphocyte separation medium (Cappel, Aurora, OH) according to instructions of manufacturer, and stored in lysis buffer (Qiagen, Valencia, CA) (10x106 cells/600 microl of lysis buffer) at -80degreesC until RNA isolation. The GALT samples were cut into 20-30 mg pieces, placed in 5 volumes of RNAlater (Ambion, Austin, TX), incubated at 4degreesC overnight and stored at -20degreesC until RNA extraction. From the 5 animals inoculated with SHIVKu1, samples of EDTA blood were obtained at PID 0 and 14 in order to compare measurements of a) plasma viral load, b) peripheral CD4+ T cell counts and c) CC-chemokine gene expression between SHIVSF162P4- and SHIVKu1-infected macaques.
###end p 49
###begin title 50
RNA isolation and cDNA preparation
###end title 50
###begin p 51
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Total RNA was isolated from 20-30 mg of GALT tissue or 10x106 of PBMC using the RNeasy mini kit (Qiagen, Valencia, CA). Prior to RNA isolation, tissue was homogenized by 3 pulses of sonication, each at 60 W for 3 sec. All samples were treated with RNase-free DNase (Qiagen). cDNA was prepared using the random hexamer primers (Integrated DNA Technologies, Skokie, IL) and M-MLV reverse transcriptase (Promega, Madison, WI) according to instructions of manufacturer.
###end p 51
###begin title 52
Evaluation of chemokine gene expression by real-time PCR
###end title 52
###begin p 53
###xml 292 293 288 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1011 1018 961 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000726-t002">Table 2</xref>
###xml 1545 1558 1489 1494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 1566 1570 1502 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Livak1">[36]</xref>
###xml 1739 1744 1675 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g001">Fig 1</xref>
###xml 1749 1750 1685 1686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000726-g002">2</xref>
Real-time PCR was carried out using the ABI Prism 7700 Sequence Detection System (Applied Biosystem, Foster City, CA). Each PCR reaction included 12.5 microl of master mix (DyNAmo HS SYBR Green qPCR Kit, MJ research, Waltham, MA). It contained modified DNA polymerase, SYBR Green I, 5 mM MgCl2, dNTP mix, 0.5 microM of forward and reverse primers, 1xROX reference dye, and 100 ng of the first strand cDNA in deionized water. After heating each sample to 95degreesC for 15 min, 40 cycles of 94degreesC for 10 sec, 55degreesC for 30 sec, and 72degreesC for 30 sec followed. After the thermal cycles, melting curves of the amplicons were generated by heating the reaction mixture to 95degreesC for 15 sec, then to 60degreesC for 20 sec, and slowly increasing the temperature to 95degreesC over a period of 20 min. The fluorescence was measured as a function of temperature. All samples were run in duplicates and the PCRs for the housekeeping glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the target genes (Table 2) were run in parallel for each sample. PCR reactions were carried out on a 96-well plate (Applied Biosystems, Foster City, CA) using the 25 microl/reaction volumes. Results were analyzed by SDS 1.9.1 Software (Applied Biosystems). The melting curves were obtained with ABI Prism 7700 software, version 1.7(, ABI). The specificity of real-time PCR was verified by melting curve analysis. Housekeeping gene GAPDH was used to normalize the RNA in tested samples. The variation in GAPDH Ct value among the RNA samples was </=3%. 2-DeltaDeltaCt method [36] was used in calculating the fold-relationships in gene expression between the time points. Pre-infection (PID 0) was used as calibrator to generate the graphs shown in Fig 1 and 2.
###end p 53
###begin title 54
###xml 0 14 <span type="species:ncbi:9544">Rhesus macaque</span>
Rhesus macaque-specific primers for real-time PCR
###end title 54
###begin title 55
Evaluation of viral loads by real-time PCR
###end title 55
###begin p 56
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Cline1">[37]</xref>
###xml 94 98 <span type="species:ncbi:12721">SHIV</span>
Quantitative assessment of viral RNA load in plasma samples obtained from peripheral blood of SHIV-inoculated macaques was determined by real-time reverse transcriptase PCR as described in detail elsewhere [37]. The virus used in this study was accurately and equivalently quantified in this assay. The values were expressed as viral RNA copies per ml of plasma.
###end p 56
###begin title 57
Enumeration of CCL4-producing cells in MLN by confocal microscopy
###end title 57
###begin p 58
###xml 182 186 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Ramesh1">[38]</xref>
###xml 965 969 961 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000726-Ramesh1">[38]</xref>
###xml 231 237 <span type="species:ncbi:9793">donkey</span>
###xml 418 422 <span type="species:ncbi:12721">SHIV</span>
###xml 475 478 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
MLN biopsies obtained from 3 animals prior to infection (PID 0) and at PID 14 were cryosectioned to 10-16 microm and subjected to immunofluorescence staining as previously described [38]. Briefly, the tissues were blocked with 10% donkey serum (Sigma, St. Louis, MO) in PBS containing 0.2% fish skin gelatin (Sigma, St. Louis, MO). The sections were subsequently stained with primary antibodies to detect CCL4+ cells, SHIV-infected cells, T cells and macrophages (anti-CCL4, SIV gag p28, CD3, and CD68 antibodies were purchased from R&D Systems, Microbix, Dako and BD Pharmingen, respectively). Negative-control samples were stained with matched isotype control antibodies and no positive cells were identified (not shown). Primary staining was followed by incubation with secondary antibodies conjugated to fluorochromes. Images were captured by a Leica TCS SP2 laser-scanning microscope (Leica Microsystems, Exton, PA) and viewed using the Leica imaging software [38].
###end p 58
###begin title 59
Flow cytometry analysis of CCL4 expression in CD3+CD4+/CD8+ T cells
###end title 59
###begin p 60
###xml 526 527 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1212 1213 1187 1188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 152 167 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 714 720 <span type="species:ncbi:9913">bovine</span>
Presence of intracellular CCL4 in PBMC was evaluated by four-color flow cytometry. The following anti-human monoclonal antibodies that cross-react with rhesus macaques were used: Phycoerythrin (PE)-conjugated anti-MIP-1beta/CCL4 (clone D21-1351), Fluorescein isothiocyanate (FITC)-conjugated anti-CD3 (clone SP34), Peridinin Chlorophyll (PerCP)-conjugated anti-CD8 (clone SK1), and Allophycocyanin (APC)-conjugated anti-CD4 (clone SK3). All antibodies were purchased from BD-Pharmingen (Pharmingen, San Diego, CA). PBMCs (5x105 per sample) were first incubated with fluorochrome-conjugated antibodies to CD3, CD4 and CD8 at 4degreesC, in dark, for 30 min. The cells were then washed with PBS containing 0.2% fetal bovine serum (FBS, Invitrogen, Chicago, IL), and permeabilized with 1x fixation/permeabilization solution (BD Biosciences) for 10 min at room temperature. Following two washes with PBS containing 0.2% FBS, the cells were incubated with anti-CCL4 for 30 min at 4degreesC. After washing, cells were resuspended in 2% paraformaldehyde/PBS. Positive control PBMCs were stimulated with 100 ng/ml of phorbol myristate acetate (PMA, Sigma) and 1 microg/ml of ionomycin (Sigma) for 6 h at 37degreesC, 5% CO2. Brefeldin-A (10 microg/ml, Sigma) was added for final 5 h. Mitogen-stimulated control PBMCs were stained and processed as described above for unstimulated samples. Negative-control samples were stained with matched isotype control antibodies. Stained cells were kept protected from light at 4degreesC and acquisition was completed within 48 h. Data acquisition was performed using the FACS-Aria Flow Cytometer (BD Biosciences), and collected data were analyzed by Cell Quest software (Becton Dickinson).
###end p 60
###begin title 61
Statistical analysis
###end title 61
###begin p 62
###xml 193 200 193 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 377 384 377 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 394 397 394 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
CCL3, CCL4 and CCL5 mRNA levels, CCL4+ cell numbers in MLN and percentages of CCL4+ cells in peripheral blood CD4+ and CD8+ T cell populations were compared between selected time points of SHIVSF162P4-infected macaques by Student's t test and a p<0.05 was considered statistically significant. In addition, the extent of CC-chemokine down-regulation in peripheral blood of SHIVSF162P4- and SHIVKu1-infected macaques was compared at PID 14 by Student's t test (p<0.05).
###end p 62
###begin p 63
###xml 207 214 207 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF162P4</sub>
###xml 223 226 223 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ku1</sub>
###xml 247 251 <span type="species:ncbi:12721">SHIV</span>
The technical assistance of Julie Bruhn, Mayra Cantu, Tessa Williams, Mike Piatak, Drs. Pyone P. Aye and Jason Dufour is greatly appreciated. We thank Dr. Preston A. Marx's laboratory for preparation of SHIVSF162P4 and SHIVKu1 inoculation stocks. SHIV viral load assays were performed by the Quantitative Molecular Diagnostic Core of the AIDS Vaccine Program, SAIC-Frederick, Inc., NCI-Frederick, MD.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
Chemokine control of lymphocyte trafficking: a general overview.
###end article-title 65
###begin article-title 66
Chemokines: a new classification system and their role in immunity.
###end article-title 66
###begin article-title 67
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
###end article-title 67
###begin article-title 68
###xml 15 18 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Chemokines and HIV: a remarkable synergism.
###end article-title 68
###begin article-title 69
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 102 107 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.
###end article-title 69
###begin article-title 70
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection.
###end article-title 70
###begin article-title 71
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.
###end article-title 71
###begin article-title 72
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 28 56 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 57 86 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5.
###end article-title 72
###begin article-title 73
###xml 67 70 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.
###end article-title 73
###begin article-title 74
###xml 14 43 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 45 48 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 131 134 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV.
###end article-title 74
###begin article-title 75
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Role of beta-chemokines in suppressing HIV replication.
###end article-title 75
###begin article-title 76
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.
###end article-title 76
###begin article-title 77
###xml 103 107 <span type="species:ncbi:12721">SHIV</span>
Spontaneous production of RANTES and antigen-specific IFN-gamma production in macaques vaccinated with SHIV-4 correlates with protection against SIVsm challenge.
###end article-title 77
###begin article-title 78
###xml 66 69 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 91 94 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Cote d'Ivoire.
###end article-title 78
###begin article-title 79
###xml 68 96 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 113 128 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 177 206 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum.
###end article-title 79
###begin article-title 80
###xml 82 111 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates.
###end article-title 80
###begin article-title 81
###xml 8 13 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
###end article-title 81
###begin article-title 82
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor.
###end article-title 82
###begin article-title 83
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.
###end article-title 83
###begin article-title 84
###xml 110 138 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 139 143 <span type="species:ncbi:12721">SHIV</span>
Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
###end article-title 84
###begin article-title 85
###xml 187 216 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection.
###end article-title 85
###begin article-title 86
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infection initiates changes in the expression of a wide array of genes in U937 promonocytes and HUT78 T cells.
###end article-title 86
###begin article-title 87
Quantitation of simian cytokine and beta-chemokine mRNAs, using real-time reverse transcriptase-polymerase chain reaction: variations in expression during chronic primate lentivirus infection.
###end article-title 87
###begin article-title 88
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV and inflammation.
###end article-title 88
###begin article-title 89
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 53 58 <span type="species:ncbi:9606">human</span>
HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages.
###end article-title 89
###begin article-title 90
###xml 26 29 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 80 83 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis.
###end article-title 90
###begin article-title 91
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors.
###end article-title 91
###begin article-title 92
MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.
###end article-title 92
###begin article-title 93
Chemokines as regulators of T cell differentiation.
###end article-title 93
###begin article-title 94
###xml 72 77 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Role of CD8+ cell-produced anti-viral factors in protective immunity in HIV-2-exposed but seronegative macaques resistant to intrarectal SIVsm challenge.
###end article-title 94
###begin article-title 95
###xml 60 89 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 118 146 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.
###end article-title 95
###begin article-title 96
Lymphocyte traffic control by chemokines.
###end article-title 96
###begin article-title 97
###xml 57 62 <span type="species:ncbi:9606">human</span>
IFN-beta stimulates the production of beta-chemokines in human peripheral blood monocytes. Importance of macrophage differentiation.
###end article-title 97
###begin article-title 98
###xml 47 75 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 77 81 <span type="species:ncbi:12721">SHIV</span>
In vitro infection of primate PBMC with simian/human immunodeficiency virus, SHIV(SF33A): correlation to in vivo outcome.
###end article-title 98
###begin article-title 99
###xml 16 44 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 102 121 <span type="species:ncbi:9545">pig-tailed macaques</span>
Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques.
###end article-title 99
###begin article-title 100
###xml 84 97 84 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;Ct</sup>
Analysis of relative gene expression data using real-time quantitative PCR and the 2-DeltaDeltaCt Method.
###end article-title 100
###begin article-title 101
###xml 17 20 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.
###end article-title 101
###begin article-title 102
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 52 66 <span type="species:ncbi:9544">rhesus macaque</span>
Visualizing cytokine-secreting cells in situ in the rhesus macaque model of chronic gut inflammation.
###end article-title 102
###begin p 103
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 103
###begin p 104
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants AI54146 and RR00164 from the National Institutes of Health.
###end p 104

